Home Cart Sign in  
Chemical Structure| 828934-41-4 Chemical Structure| 828934-41-4

Structure of Etomoxir sodium salt
CAS No.: 828934-41-4

Chemical Structure| 828934-41-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

(R)-(+)-etomoxir sodium salt is inhibitor of carnitine palmitoyltransferase I (CPT1) and can reduce β-oxidation in mitochondria. It shows inhibition of cardiolipin biosynthesis.

Synonyms: (R)-(+)-Etomoxir Sodium; (+)-Etomoxir (sodium salt); (R)-(+)-Etomoxir

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Etomoxir sodium salt

CAS No. :828934-41-4
Formula : C15H18ClNaO4
M.W : 320.74
SMILES Code : O=C([C@]1(CCCCCCOC2=CC=C(Cl)C=C2)OC1)[O-].[Na+]
Synonyms :
(R)-(+)-Etomoxir Sodium; (+)-Etomoxir (sodium salt); (R)-(+)-Etomoxir
MDL No. :MFCD07787411
InChI Key :RPACBEVZENYWOL-XFULWGLBSA-M
Pubchem ID :57345784

Safety of Etomoxir sodium salt

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
MDSCs 4 μM 3 h To inhibit fatty acid oxidation and evaluate its impact on the metabolism and function of MDSCs. PMC9081115
Endothelial Cells Not mentioned Not mentioned Etomoxir inhibited mitochondrial long-chain fatty acid oxidation (FAO) and reduced endothelial cell proliferation, but did not affect their migration. PMC4413024
NK cells 150 µM 3 and 6 h Inhibited fatty acid oxidation, significantly suppressing the respiration of IL-10 stimulated NK cells PMC7940510
BMDMs 5µM 18h Inhibition of fatty acid oxidation to restore TNF and IL-6 production PMC9905698

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
mice C57BL/6J mice oral 50 mg/kg single dose Measure heart 2-DG uptake, results showed Etomoxir significantly increased heart 2-DG uptake PMC3028366
Mice FBPase transgenic mice Oral 10 mg/kg Single dose To investigate the effect of Etomoxir on food intake, results showed that 24 hours after Etomoxir treatment, food intake in transgenic mice increased and normalized to the level of the vehicle and inhibitor-treated negative littermates. PMC3331739
Mice C57BL/6 mice Intraperitoneal injection 20 mg/kg 24 hours prior to infection and on the day of infection To evaluate the effect of Etomoxir on the metabolic and immune responses in MKP103-infected mice, results showed increased bacterial loads and enhanced inflammatory responses in Etomoxir-treated mice. PMC9081115
Mice OVA or HDM-induced asthma models Intraperitoneal injection 50 mg/Kg Two injections, 24 hours apart Etomoxir significantly decreased allergen-induced airway hyperresponsiveness, reduced the number of inflammatory cells, and decreased the production of cytokines and chemokines associated with asthma. PMC5578913
Mice C57BL/6 wild type mice Intraperitoneal injection 30-35 mg/kg Once daily from P2 to P4 Etomoxir inhibited FAO, causing retinal vascular defects in mice and reducing pathological angiogenesis in a model of retinopathy of prematurity (ROP). PMC4413024
Mice Hyperglycemia-induced suppression of physiological retinal vessel growth model Intraperitoneal injection 4 mg/kg Once daily from P7 to P9 Etomoxir significantly attenuated the promotion of physiological retinal vessel growth by FGF21 through inhibition of mitochondrial fatty acid oxidation. PMC10328855

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.12mL

0.62mL

0.31mL

15.59mL

3.12mL

1.56mL

31.18mL

6.24mL

3.12mL

References

 

Historical Records

Categories